Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Clumeck

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
HIV Medicine|September 17, 2013
Feasibility and acceptability of HIV screening through the use of rapid tests by general practitioners in a Brussels area with a substantial African communityA-F Gennotte, P Semaille, C Ellis, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 12, 1998
Cytomegalovirus retinitis in patients with AIDS in Europe. AIDS in Europe Study GroupM Burke, I Yust, C Katlama, et al.
AIDS (London, England)|December 1, 1996
Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection. G-CSF 92105 Study GroupP Hermans, W Rozenbaum, A Jou, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 9, 1997
Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study GroupJ D Lundgren, A N Phillips, S Vella, et al.
AIDS (London, England)|December 22, 1999
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study TeamR Haubrich, M Thompson, R Schooley, et al.
Antiviral Therapy|August 9, 2001
A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experienceR T Schooley, N Clumeck, R Haubrich, et al.
Antiviral Therapy|January 1, 1996
Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients. Loviride Collaborative Study GroupS Staszewski, V Miller, A Kober, et al.
The New England Journal of Medicine|December 1, 2006
CD4+ count-guided interruption of antiretroviral treatment, W M El-Sadr, J D Lundgren, et al.
Plos One|November 13, 2015
Auditing HIV Testing Rates across Europe: Results from the HIDES 2 StudyD Raben, A Mocroft, M Rayment, et al.
Antiviral Therapy|January 18, 2005
Updated European recommendations for the clinical use of HIV drug resistance testingA M Vandamme, A Sönnerborg, M Ait-Khaled, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
HIV Medicine|September 17, 2013
Feasibility and acceptability of HIV screening through the use of rapid tests by general practitioners in a Brussels area with a substantial African communityA-F Gennotte, P Semaille, C Ellis, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 12, 1998
Cytomegalovirus retinitis in patients with AIDS in Europe. AIDS in Europe Study GroupM Burke, I Yust, C Katlama, et al.
AIDS (London, England)|December 1, 1996
Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection. G-CSF 92105 Study GroupP Hermans, W Rozenbaum, A Jou, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 9, 1997
Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study GroupJ D Lundgren, A N Phillips, S Vella, et al.
AIDS (London, England)|December 22, 1999
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study TeamR Haubrich, M Thompson, R Schooley, et al.
Antiviral Therapy|August 9, 2001
A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experienceR T Schooley, N Clumeck, R Haubrich, et al.
Antiviral Therapy|January 1, 1996
Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients. Loviride Collaborative Study GroupS Staszewski, V Miller, A Kober, et al.
The New England Journal of Medicine|December 1, 2006
CD4+ count-guided interruption of antiretroviral treatment, W M El-Sadr, J D Lundgren, et al.
Plos One|November 13, 2015
Auditing HIV Testing Rates across Europe: Results from the HIDES 2 StudyD Raben, A Mocroft, M Rayment, et al.
Antiviral Therapy|January 18, 2005
Updated European recommendations for the clinical use of HIV drug resistance testingA M Vandamme, A Sönnerborg, M Ait-Khaled, et al.
Pageof 20